Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries

por Montinaro, Antonella, Walczak, Henning
Publicado 2022

Ubiquitin in the immune system

por Zinngrebe, Julia, Montinaro, Antonella, Peltzer, Nieves, Walczak, Henning
Publicado 2014

Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice

por Montinaro, Antonella, Forte, Giovanni, Sorrentino, Rosalinda, Luciano, Antonio, Palma, Giuseppe, Arra, Claudio, Adcock, Ian M., Pinto, Aldo, Morello, Silvana
Publicado 2012

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells

por Tuthill, Mark H, Montinaro, Antonella, Zinngrebe, Julia, Prieske, Katharina, Draber, Peter, Prieske, Stefan, Newsom-Davis, Tom, von Karstedt, Silvia, Graves, Jonathan, Walczak, Henning
Publicado 2014

The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2

por Hartwig, Torsten, Montinaro, Antonella, von Karstedt, Silvia, Sevko, Alexandra, Surinova, Silvia, Chakravarthy, Ankur, Taraborrelli, Lucia, Draber, Peter, Lafont, Elodie, Arce Vargas, Frederick, El-Bahrawy, Mona A., Quezada, Sergio A., Walczak, Henning
Publicado 2017

Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers

por Montinaro, Antonella, Areso Zubiaur, Itziar, Saggau, Julia, Kretz, Anna-Laura, Ferreira, Rute M. M., Hassan, Omar, Kitzig, Ella, Müller, Ines, El-Bahrawy, Mona A., von Karstedt, Silvia, Kulms, Dagmar, Liccardi, Gianmaria, Lemke, Johannes, Walczak, Henning
Publicado 2021

LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L

por Taraborrelli, Lucia, Peltzer, Nieves, Montinaro, Antonella, Kupka, Sebastian, Rieser, Eva, Hartwig, Torsten, Sarr, Aida, Darding, Maurice, Draber, Peter, Haas, Tobias L., Akarca, Ayse, Marafioti, Teresa, Pasparakis, Manolis, Bertin, John, Gough, Peter J., Bouillet, Philippe, Strasser, Andreas, Leverkus, Martin, Silke, John, Walczak, Henning
Publicado 2018

A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targets

por Li, Xiang, Huang, Chun-Hao, Sánchez-Rivera, Francisco J., Kennedy, Margaret C., Tschaharganeh, Darjus F., Morris, John P., Montinaro, Antonella, O'Rourke, Kevin P., Banito, Ana, Wilkinson, John E., Chen, Chi-Chao, Ho, Yu-Jui, Dow, Lukas E., Tian, Sha, Luan, Wei, de Stanchina, Elisa, Zhang, Tinghu, Gray, Nathanael S., Walczak, Henning, Lowe, Scott W.
Publicado 2022

LUBAC is essential for embryogenesis by preventing cell death and enabling haematopoiesis

por Peltzer, Nieves, Darding, Maurice, Montinaro, Antonella, Draber, Peter, Draberova, Helena, Kupka, Sebastian, Rieser, Eva, Fisher, Amanda, Hutchinson, Ciaran, Taraborrelli, Lucia, Hartwig, Torsten, Lafont, Elodie, Haas, Tobias L., Shimizu, Yutaka, Böiers, Charlotta, Sarr, Aida, Rickard, James, Alvarez-Diaz, Silvia, Ashworth, Michael T., Beal, Allison, Enver, Tariq, Bertin, John, Kaiser, William, Strasser, Andreas, Silke, John, Bouillet, Philippe, Walczak, Henning
Publicado 2018

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells

por Kolluri, Krishna Kalyan, Alifrangis, Constantine, Kumar, Neelam, Ishii, Yuki, Price, Stacey, Michaut, Magali, Williams, Steven, Barthorpe, Syd, Lightfoot, Howard, Busacca, Sara, Sharkey, Annabel, Yuan, Zhenqiang, Sage, Elizabeth K, Vallath, Sabarinath, Le Quesne, John, Tice, David A, Alrifai, Doraid, von Karstedt, Sylvia, Montinaro, Antonella, Guppy, Naomi, Waller, David A, Nakas, Apostolos, Good, Robert, Holmes, Alan, Walczak, Henning, Fennell, Dean A, Garnett, Mathew, Iorio, Francesco, Wessels, Lodewyk, McDermott, Ultan, Janes, Samuel M
Publicado 2018